Prednisone and Acupuncture for the Treatment of Facial Neuritis: a Multiple Center, CER in China

Air Force Military Medical University of People's Liberation Army

Status: Unknown

Conditions: Bell's Palsy

Treatments: Other: other treatment; Device: acupuncture; Drug: Prednisolone

Study type: Interventional

Funder types: Other

Identifiers

NCT01201642

XijingNeuro-2010

Details and patient eligibility

About

The aim of this study is to compare the effects of prednisolone and staging acupuncture in the recovery of the affected facial nerve, and to verify that whether in combination with staging acupuncture is more effective than prednisolone alone for Bell's palsy in a large number of patients.

Full description

Patients will be recruited between Sep, 2010, and Dec, 2014. Baseline assessments before the start of treatment include neurological examination, grading of facial function, measurement of ipsilateral pain, documentation of concurrent medication.

These patients are assigned to receive one of the following treatment groups, i.e. 1)the hormone group: oral hormone drugs, do not accept acupuncture treatment; 2)acupuncture group: using acupuncture therapy, do not accept oral hormone therapy; 3)hormone-acupuncture combined treatment group: receive oral hormone and acupuncture therapy at the same time; 4)other treatment group: other treatment in addition to the above 3 groups of treatment abroad. The secondary factor grouping (subgroup): According to the different time of treatment after the onset of disease, the acupuncture group and the hormone- acupuncture combined treatment group can be divided into Type Ⅰ subgroup (patients receive acupuncture within 10 days of the onset of disease) and Type II subgroups (patients receive acupuncture after 10 days of the onset of disease). The primary outcome is the time to complete recovery of facial function, assessed by Sunnybrook system and House-Brackmann scale. The secondary outcomes include the incidence of ipsilateral pain in the early stage of palsy (and the duration of this pain), the proportion of patients with severe pain, the occurrence of synkinesis, facial spasm or contracture, and the severity of residual facial symptoms during the study period.

Enrollment: 1,800 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• involvement of unilateralfacial nerve paralysis only
• aged between 18 and 75 years old
• period of onset of facial paralysis within 72h

Exclusion criteria

• pregnancy
• breastfeeding
• being a woman of child bearing age who is unwilling to use contraceptives during the medication period
• other neurological diseases
• diabetes
• badly controlled hypertension
• current or a history of serious heart disease
• history of renal or hepatic disease
• gastric or duodenal ulcer
• history of glaucoma
• acute otitis or history of ipsilateral chronic otitis
• history of tuberculosis, history of immunodeficiency syndromes
• recent head injury, psychiatric disease, or any other condition that is at risk of being influenced by the study medication or that might have affected completion of the study.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,800 participants in 6 patient groups

Prednisolone

Experimental group

Description:

Prednisolone as 5 mg tablets will be given within 72 h after onset of Bell's palsy as a single dose of 40 mg daily for 5 days; the dose will then be reduced by 10 mg per 5 day, with a total treatment time of 20 days.

Treatment:

Drug: Prednisolone

Acute stage acupuncture

Experimental group

Description:

Accept acupuncture therapy within 10days after onset of Bell's palsy, do not accept prednisolone therapy. The acupuncture points used were Dicang (ST4), Jiache (ST6), Yangbai (GB14), Xiaguan (ST7), Taiyang (EX-HN5), Quanliao (SI18) and Yifeng (TE17) on the affected side, and Hegu (LI4) bilaterally. For acute stages acupuncture, shallow puncturing is used at facial acupoints and routine puncturing is used at other acupoints within 72 h after onset of Bell's palsy. Yifeng (TE17), Hegu (LI4) are punctured 0.5-1.0 cun, the others are punctured 0.1-0.3 cun. and the needles were retained for 30 minutes, once a day, five times a week, for a total period of four weeks.

Treatment:

Device: acupuncture

Prednisolone + acute stage acupuncture

Experimental group

Description:

Accept prednisolone and acupuncture therapy within 10days after onset of Bwll's palsy. Prednisolone used as same as the Arm of Prednisolone. The acupuncture points used as same as the Arm of Acute stage acupuncture.

Treatment:

Device: acupuncture

Drug: Prednisolone

Resting stage acupuncture

Experimental group

Description:

Accepted acupuncture therapy after 10 days of the onset of Bell's palsy. The acupuncture points used were Dicang (ST4), Jiache (ST6), Yangbai (GB14), Xiaguan (ST7), Taiyang (EX-HN5), Quanliao (SI18) and Yifeng (TE17) on the affected side, and Hegu (LI4) bilaterally. Penetrative needling is used from Dicang (ST4) to Jiache (ST6) and from Taiyang (EX-HN5) to Quanliao (SI18) 2-3 cun, and routine puncturing is used at other acupoints 7 d after enrolment. Filiform needles (33 - 49.5 mm, 0.32 mm) will be used with moderate stimulation to get an acupuncture sensation, and the needles were retained for 30 minutes, once a day, five times a week, for a total period of four weeks.

Treatment:

Device: acupuncture

Prednisolone + resting stage acupuncture

Experimental group

Description:

Accept prednisolone and acupuncture therapy more than 10days after onset of Bwll's palsy. Prednisolone used as same as the Arm of Prednisolone. The acupuncture points used as same as the Arm of Resting stage acupuncture.

Treatment:

Device: acupuncture

Drug: Prednisolone

Other treatment

Other group

Description:

Do not accept neither prednisolone nor acupuncture therapy. The therapy accepted is different from the five Arms Previously.

Treatment:

Other: other treatment